Recent advances in Tumor Treating Fields

Review Progress and prospect in tumor treating fields treatment of ...

Presently, several new therapies, such as immunotherapy and targeted molecular therapy are available; however, the prognosis of these therapies is yet ...

Therapeutic potential of tumor treating fields for malignant brain tumors

Recent studies have shown that TTFields can alter the bioelectrical state of macromolecules and organelles involved in cancer biology. Massive ...

Effect of Tumor-Treating Fields Plus Maintenance Temozolomide vs ...

Importance Tumor-treating fields (TTFields) is an antimitotic treatment modality that interferes with glioblastoma cell division and ...

Tumor treating fields in the management of Glioblastoma

Alternating electric fields have been successfully applied to cancer cells in-vitro to disrupt malignant progression and this antimitotic ...

Tumor treating fields: narrative review of a promising treatment ...

Background and Objective: Tumor treating fields (TTFields) therapy have emerged as a potentially effective treatment for various malignancies by delivering low- ...

Tumor Treating Fields in the Management of Patients with Malignant ...

Tumor treating fields (TTFields) have emerged as a novel, locoregional, antineoplastic treatment modality with favorable efficacy and safety being demonstrated.

Efficacy and Safety of Treating Glioblastoma With Tumor-Treating ...

Tumor-treating fields (TTFields) therapy, delivered via a noninvasive device, is a new therapy approved for use in patients with recurrent GBM and in ...

New Data Finds Tumor Treating Fields Initiates Downstream Anti ...

The TTFields global development program includes a network of preclinical collaborators and a broad range of clinical trials across all phases, ...

Tumor treating fields for the treatment of glioblastoma

Results: Recent trials have shown promising results both in patients with nGBM and rGBM/progressive (rGBM), leading to Food and Drug ...

Study shows TTFields holds promise to potentially trigger immune ...

New research shows Tumor Treating Fields could stimulate an immune system response against recurrent glioblastoma.

Novocure Trials: Novocure Cancer Clinical Trials

Novocure is the sponsor of several clinical studies investigating TTFields treatment for different types of cancer.

Efficacy of tumour-treating fields therapy in recurrent glioblastoma

This review synthesizes the current evidence surrounding the efficacy of TTFields Therapy in the context of recurrent Glioblastoma.

Technological Advances in the Treatment of Cancer: Combining ...

Abstract: The anticancer treatment modality tumor treating fields (TTFields; Optune, Novocure) use the lower frequency range of the electromagnetic spectrum to ...

Treatment with Tumor Treating Fields triggers downstream anti ...

Novocure announced that a new study published in the Journal of Clinical Investigation (JCI) finds treatment with Tumor Treating Fields ...

Tumor-Treating Fields: A Bold Innovation Improving Patient ... - CCO

In this online program, experts discuss advances in the use of tumor-treating fields (TTFields) for solid tumors. Read an expert commentary on the LUNAR ...

Tumour Treating Fields (TTF) or Optune®

Tumour treating fields, also known as TTF or TT Fields, is a relatively new, non-invasive technique for adults with a type of brain tumour called a ...

Full article: Tumor treating fields: a new treatment for glioblastoma

A new method that is intended to prolong the progression-free survival is using electromagnetic alternating fields, the so-called tumor treating fields (TTF).

LBA3 Tumor Treating Fields (TTFields) therapy plus XELOX ...

Tumor Treating Fields (TTFields) therapy is a locoregional, noninvasive treatment approved for glioblastoma and mesothelioma. TTFields, electric fields that ...

Tumor treating fields (TTFields) delay DNA damage repair following ...

Tumor Treating Fields (TTFields) are an anti-neoplastic treatment modality delivered via application of alternating electric fields using ...

The Impact of Tumor Treating Fields on Glioblastoma Progression ...

For the current study, we analyzed data of 428. (62%) patients who had progressed during the trial observa- tion period and for whom imaging was available at ...